Correlation of anti-emetic efficacy and plasma levels of ondansetron
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (8) , 879-882
- https://doi.org/10.1016/0277-5379(90)90190-5
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNSEuropean Journal of Pharmacology, 1988
- Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy.Journal of Clinical Oncology, 1988
- THE ROLE OF THE ABDOMINAL VISCERAL INNERVATION AND 5‐HYDROXYTRYPTAMINE M‐RECEPTORS IN VOMITING INDUCED BY THE CYTOTOXIC DRUGS CYCLOPHOSPHAMIDE AND CIS‐PLATIN IN THE FERRETQuarterly Journal of Experimental Physiology, 1988
- Antiemetic properties of the 5HT3-receptor antagonist, gr38032fCancer Treatment Reviews, 1987
- Identification and distribution of 5-HT3 receptors in rat brain using radioligand bindingNature, 1987
- PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONISTThe Lancet, 1987
- FIRST RESULTS WITH ICS 205-930 (5-HT3 RECEPTOR ANTAGONIST) IN PREVENTION OF CHEMOTHERAPY-INDUCED EMESISThe Lancet, 1987
- 5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesisNeuropharmacology, 1986
- Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonismBritish Journal of Pharmacology, 1986
- The enteric neural receptor for 5-hydroxytryptamineCellular and Molecular Life Sciences, 1985